International Graphite (ASX: IG6) strikes European graphite processing JV with Italian chemical group ALKEEMIA at Porto Marghera
Infosys agrees to acquire Optimum Healthcare IT for $465m in its second-largest deal, targeting AI-led transformation of US provider market
The Las Vegas Strip just got a pricing experiment, and MGM Resorts International is betting guests will notice
Read More 6 minute read Pharma Industry News How Syndax’s Revuforj (revumenib) became the first FDA-approved menin inhibitor for acute leukemia patients Find out how Syndax’s Revuforj (revumenib) became the first FDA-approved menin inhibitor for acute leukemia, transforming treatment and investor sentiment alike. bySoujanya RaviOctober 24, 2025